Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Successful validation of a larval dispersal model using genetic parentage data.

Bode M, Leis JM, Mason LB, Williamson DH, Harrison HB, Choukroun S, Jones GP.

PLoS Biol. 2019 Jul 12;17(7):e3000380. doi: 10.1371/journal.pbio.3000380. [Epub ahead of print]

2.

Do tiny fish rule the reefs?

Riginos C, Leis JM.

Science. 2019 Jun 21;364(6446):1128-1130. doi: 10.1126/science.aax8961. No abstract available.

PMID:
31221842
3.

Clinical characteristics and outcomes of Richter transformation: Experience of 204 patients from a single center.

Wang Y, Tschautscher MA, Rabe KG, Call TG, Leis JF, Kenderian SS, Kay NE, Muchtar E, Van Dyke DL, Koehler AB, Schwager SM, Slager SL, Parikh SA, Ding W.

Haematologica. 2019 Jun 13. pii: haematol.2019.224121. doi: 10.3324/haematol.2019.224121. [Epub ahead of print]

4.

Association of Increased Colony-Count Threshold for Urinary Pathogens in Hospitalized Patients With Antimicrobial Treatment.

Smith MA, Puckrin R, Lam PW, Lamb MJ, Simor AE, Leis JA.

JAMA Intern Med. 2019 Apr 29. doi: 10.1001/jamainternmed.2019.0188. [Epub ahead of print] No abstract available.

PMID:
31033997
5.

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

Hampel PJ, Ding W, Call TG, Rabe KG, Kenderian SS, Witzig TE, Muchtar E, Leis JF, Chanan-Khan AA, Koehler AB, Fonder AL, Schwager SM, Slager SL, Shanafelt TD, Kay NE, Parikh SA.

Leuk Lymphoma. 2019 Apr 24:1-8. doi: 10.1080/10428194.2019.1602268. [Epub ahead of print]

PMID:
31014142
6.

Understanding interactions between plasticity, adaptation and range shifts in response to marine environmental change.

Donelson JM, Sunday JM, Figueira WF, Gaitán-Espitia JD, Hobday AJ, Johnson CR, Leis JM, Ling SD, Marshall D, Pandolfi JM, Pecl G, Rodgers GG, Booth DJ, Munday PL.

Philos Trans R Soc Lond B Biol Sci. 2019 Mar 18;374(1768):20180186. doi: 10.1098/rstb.2018.0186.

PMID:
30966966
7.

Improving healthcare worker adherence to the use of transmission-based precautions through application of human factors design: a prospective multi-centre study.

Williams VR, Leis JA, Trbovich P, Agnihotri T, Lee W, Joseph B, Glen L, Avaness M, Jinnah F, Salt N, Powis JE.

J Hosp Infect. 2019 Mar 30. pii: S0195-6701(19)30148-3. doi: 10.1016/j.jhin.2019.03.014. [Epub ahead of print]

8.

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy.

Sinha S, Boysen JC, Chaffee KG, Kabat BF, Slager SL, Parikh SA, Secreto CR, Call T, Shanafelt TD, Leis JF, Warner SL, Bearss DJ, Ghosh AK, Kay NE.

Oncotarget. 2018 Dec 14;9(98):37173-37184. doi: 10.18632/oncotarget.26444. eCollection 2018 Dec 14.

9.

Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?

Jain T, Kunze KL, Khetarpal BK, McCallen MR, Betcher JA, Ofori HT, Khera N, Slack JL, Leis JF, Sproat LZ, Noel P, Palmer J.

Leuk Lymphoma. 2019 Aug;60(8):2034-2041. doi: 10.1080/10428194.2018.1562183. Epub 2019 Jan 10.

PMID:
30626239
10.

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

Fang H, Reichard KK, Rabe KG, Hanson CA, Call TG, Ding W, Kenderian SS, Muchtar E, Schwager SM, Leis JF, Chanan-Khan AA, Slager SL, Braggio E, Smoley SA, Kay NE, Shanafelt TD, Van Dyke DL, Parikh SA.

Am J Hematol. 2019 Mar;94(3):338-345. doi: 10.1002/ajh.25385. Epub 2019 Jan 8.

PMID:
30575108
11.

Standardized Cost Estimates for Home Visiting: Pilot Study of the Home Visiting Budget Assistance Tool (HV-BAT).

Yarnoff B, Khavjou O, Bradley C, Leis J, Filene J, Honeycutt A, Herzfeldt-Kamprath R, Peplinski K.

Matern Child Health J. 2019 Apr;23(4):470-478. doi: 10.1007/s10995-018-2657-0.

PMID:
30547353
12.

A database of marine larval fish assemblages in Australian temperate and subtropical waters.

Smith JA, Miskiewicz AG, Beckley LE, Everett JD, Garcia V, Gray CA, Holliday D, Jordan AR, Keane J, Lara-Lopez A, Leis JM, Matis PA, Muhling BA, Neira FJ, Richardson AJ, Smith KA, Swadling KM, Syahailatua A, Taylor MD, van Ruth PD, Ward TM, Suthers IM.

Sci Data. 2018 Oct 16;5:180207. doi: 10.1038/sdata.2018.207.

13.

Reply to Karabay and Karabay.

Dragan V, Wei Y, Elligsen M, Leis JA.

Clin Infect Dis. 2019 Mar 19;68(7):1252-1253. doi: 10.1093/cid/ciy886. No abstract available.

PMID:
30321296
14.

Hand hygiene opportunities on Canadian acute-care inpatient units: A multicenter observational study.

Nayyar D, Moore C, McCreight L, Garvida C, Xu E, Kiss A, Ricciuto DR, McGeer A, Leis JA.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1378-1380. doi: 10.1017/ice.2018.221. Epub 2018 Sep 25.

PMID:
30249307
15.

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

Hampel PJ, Larson MC, Kabat B, Call TG, Ding W, Kenderian SS, Bowen D, Boysen J, Schwager SM, Leis JF, Chanan-Khan AA, Muchtar E, Hanson CA, Slager SL, Kay NE, Chaffee KG, Shanafelt TD, Parikh SA.

Br J Haematol. 2018 Nov;183(3):421-427. doi: 10.1111/bjh.15545. Epub 2018 Aug 16.

PMID:
30117139
16.

Nosocomial outbreak of vanD-carrying vancomycin-resistant Enterococcus faecium.

Lam PW, Kozak RA, Eshaghi A, Avaness M, Salt N, Patel SN, Simor AE, Leis JA.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1266-1268. doi: 10.1017/ice.2018.174. Epub 2018 Aug 16. No abstract available.

PMID:
30111383
17.

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

Padrnos L, Ernst B, Dueck AC, Kosiorek HE, Ginos BF, Toro A, Johnston PB, Habermann TM, Leis JF, Mikhael JR, Nowakowski GS, Colgan J, Porrata L, Ansell SM, Witzig TE, Reeder C.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):664-672.e2. doi: 10.1016/j.clml.2018.06.013. Epub 2018 Jun 15.

PMID:
30104176
18.

The impact of vancomycin trough concentrations on outcomes in non-deep seated infections: a retrospective cohort study.

Wan M, Walker SAN, Martin E, Elligsen M, Palmay L, Leis JA.

BMC Pharmacol Toxicol. 2018 Jul 31;19(1):47. doi: 10.1186/s40360-018-0236-z.

19.

Economic Impact of Oral Therapies for Chronic Lymphocytic Leukemia-the Burden of Novelty.

Hilal T, Betcher JA, Leis JF.

Curr Hematol Malig Rep. 2018 Aug;13(4):237-243. doi: 10.1007/s11899-018-0461-y. Review.

PMID:
29982866
20.

Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation.

Jain T, Kosiorek HE, Grys TE, Kung ST, Shah VS, Betcher JA, Slack JL, Leis JF, Khera N, Noel P, Palmer JM, Sproat LZ.

Leuk Lymphoma. 2019 Jan;60(1):110-117. doi: 10.1080/10428194.2018.1459603. Epub 2018 Jul 6.

PMID:
29979906
21.

Predictors of Peripherally Inserted Central Catheter Occlusion in the Outpatient Parenteral Antimicrobial Therapy Setting.

Lam PW, Graham C, Leis JA, Daneman N.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00900-18. doi: 10.1128/AAC.00900-18. Print 2018 Sep.

22.

Standardisation of perioperative urinary catheter use to reduce postsurgical urinary tract infection: an interrupted time series study.

Sadeghi M, Leis JA, Laflamme C, Sparkes D, Ditrani W, Watamaniuk A, Taggar R, Jinnah F, Avaness M, Vearncombe M, Nathens AB.

BMJ Qual Saf. 2019 Jan;28(1):32-38. doi: 10.1136/bmjqs-2017-007458. Epub 2018 May 29.

PMID:
29844230
23.

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.

Jain T, Kunze KL, Temkit M, Partain DK, Patnaik MS, Slack JL, Khera N, Hogan WJ, Roy V, Noel P, Leis JF, Sproat LZ, Fauble V, Mesa RA, Palmer J.

Bone Marrow Transplant. 2019 Feb;54(2):204-211. doi: 10.1038/s41409-018-0226-1. Epub 2018 May 24.

PMID:
29795431
24.

PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.

He R, Ding W, Viswanatha DS, Chen D, Shi M, Van Dyke D, Tian S, Dao LN, Parikh SA, Shanafelt TD, Call TG, Ansell SM, Leis JF, Mai M, Hanson CA, Rech KL.

Am J Surg Pathol. 2018 Jul;42(7):843-854. doi: 10.1097/PAS.0000000000001077.

PMID:
29762141
25.

Infrared needle mapping to assist biopsy procedures and training.

Shar B, Leis J, Coucher J.

Healthc Technol Lett. 2018 Jan 26;5(2):65-69. doi: 10.1049/htl.2017.0045. eCollection 2018 Apr.

26.

Chemometric Approach to the Calibration of Light Emitting Diode Based Optical Gas Sensors Using High-Resolution Transmission Molecular Absorption Data.

Mahbub P, Leis J, Macka M.

Anal Chem. 2018 May 15;90(10):5973-5976. doi: 10.1021/acs.analchem.8b01295. Epub 2018 May 3.

PMID:
29706062
27.

Automatic notification and infectious diseases consultation for patients with Staphylococcus aureus bacteremia.

Djelic L, Andany N, Craig J, Daneman N, Simor A, Leis JA.

Diagn Microbiol Infect Dis. 2018 Jul;91(3):282-283. doi: 10.1016/j.diagmicrobio.2018.03.001. Epub 2018 Mar 3.

PMID:
29699836
28.

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, Weinberg JB, Benavente Y, Casabonne D, Liebow M, Nieters A, Hjalgrim H, Melbye M, Glimelius B, Adami HO, Boffetta P, Brennan P, Maynadie M, McKay J, Cocco PL, Shanafelt TD, Call TG, Norman AD, Hanson C, Robinson D, Chaffee KG, Brooks-Wilson AR, Monnereau A, Clavel J, Glenn M, Curtin K, Conde L, Bracci PM, Morton LM, Cozen W, Severson RK, Chanock SJ, Spinelli JJ, Johnston JB, Rothman N, Skibola CF, Leis JF, Kay NE, Smedby KE, Berndt SI, Cerhan JR, Caporaso N, Slager SL.

Blood. 2018 Jun 7;131(23):2541-2551. doi: 10.1182/blood-2017-11-814608. Epub 2018 Apr 19.

29.

Adaptation of an evidence-based postpartum depression intervention: feasibility and acceptability of mothers and babies 1-on-1.

Darius Tandon S, Leis JA, Ward EA, Snyder H, Mendelson T, Perry DF, Carter M, Hamil J, Le HN.

BMC Pregnancy Childbirth. 2018 Apr 11;18(1):93. doi: 10.1186/s12884-018-1726-0.

30.

Impact of Defaulting to Single-Lumen Peripherally Inserted Central Catheters on Patient Outcomes: An Interrupted Time Series Study.

Lam PW, Volling C, Chan T, Wiggers JB, Castellani L, Wright J, Peckham K, Shadowitz S, Tasker S, MacFadden DR, Daneman N, Gold WL, Pugash R, Leis JA.

Clin Infect Dis. 2018 Aug 31;67(6):954-957. doi: 10.1093/cid/ciy301.

PMID:
29635457
31.

Rituximab Maintenance Therapy After First-Line Induction Chemoimmunotherapy for Follicular Lymphoma.

Hilal T, Leis JF, Reeder CB.

JAMA Oncol. 2018 Jun 1;4(6):859-860. doi: 10.1001/jamaoncol.2018.0111.

PMID:
29596546
32.

Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections.

Hilal T, Gea-Banacloche JC, Leis JF.

Blood Rev. 2018 Sep;32(5):387-399. doi: 10.1016/j.blre.2018.03.004. Epub 2018 Mar 16. Review.

PMID:
29571669
33.

Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia.

Kay NE, LaPlant BR, Pettinger AM, Call TG, Leis JF, Ding W, Parikh SA, Conte MJ, Bowen DA, Shanafelt TD.

Expert Rev Hematol. 2018 Apr;11(4):337-349. doi: 10.1080/17474086.2018.1442716. Epub 2018 Feb 26.

PMID:
29460654
34.

Prophylactic Antimicrobial Therapy for Acute Aspiration Pneumonitis.

Dragan V, Wei Y, Elligsen M, Kiss A, Walker SAN, Leis JA.

Clin Infect Dis. 2018 Aug 1;67(4):513-518. doi: 10.1093/cid/ciy120.

PMID:
29438467
35.

Clinical Significance of Low Colony-Count Urine Cultures Among Hospitalized Inpatients.

Smith MA, Lamb MJ, Baillie L, Simor A, Leis JA.

Infect Control Hosp Epidemiol. 2018 Apr;39(4):488-489. doi: 10.1017/ice.2017.324. Epub 2018 Feb 12. No abstract available.

PMID:
29428000
36.

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.

Parikh SA, Chaffee KG, Larson MC, Hampel PJ, Call TG, Ding W, Kenderian SS, Leis JF, Chanan-Khan AA, Conte MJ, Bowen D, Schwager SM, Slager SL, Hanson CA, Kay NE, Shanafelt TD.

Haematologica. 2018 Jun;103(6):e237-e240. doi: 10.3324/haematol.2017.183194. Epub 2018 Feb 1. No abstract available.

37.

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

Sonbol MB, Hilal T, Dueck AC, Rosenthal AC, Conley CR, Kosiorek HE, Ginos BF, Gano KM, Nichols CS, Leis JF, Johnston PB, Habermann TM, Northfelt DW, Bergsagel PL, Inwards DJ, Witzig TE, Ansell SM, Reeder CB.

Leuk Lymphoma. 2018 Sep;59(9):2128-2134. doi: 10.1080/10428194.2017.1416368. Epub 2018 Jan 10.

PMID:
29320913
38.

Microbacterium Peritonitis in Peritoneal Dialysis: A Case Report and Review.

Lam PW, Naimark DM, Leis JA.

Perit Dial Int. 2018 Jan-Feb;38(1):9-13. doi: 10.3747/pdi.2017.00121. Review.

PMID:
29311193
39.

Tsg101 chaperone function revealed by HIV-1 assembly inhibitors.

Strickland M, Ehrlich LS, Watanabe S, Khan M, Strub MP, Luan CH, Powell MD, Leis J, Tjandra N, Carter CA.

Nat Commun. 2017 Nov 9;8(1):1391. doi: 10.1038/s41467-017-01426-2.

40.

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

Hampel PJ, Chaffee KG, King RL, Simonetto D, Larson MC, Achenbach S, Call TG, Ding W, Kenderian SS, Leis JF, Chanan-Khan AA, Bowen DA, Conte MJ, Schwager SM, Hanson CA, Slager SL, Kay NE, Shanafelt TD, Parikh SA.

Am J Hematol. 2017 Dec;92(12):1362-1369. doi: 10.1002/ajh.24915. Epub 2017 Oct 19.

41.

The Use of Intravenous and Inhaled Colistin Therapy During a Burn Center Outbreak of Multidrug-Resistant Acinetobacter baumannii.

Saun TJ, Rogers AD, Leis JA, Cartotto R.

J Burn Care Res. 2018 Oct 23;39(6):1029-1036. doi: 10.1097/BCR.0000000000000626.

PMID:
28877134
42.

Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey.

Begna K, Al-Kali A, Elliott M, Foran J, Gangat N, Hogan W, Hook C, Leis J, Litzow M, Mesa R, Palmer J, Pardanani A, Patnaik M, Rivera C, Sproat L, Tibes R, Wolanskyj-Spinner A, Tefferi A.

Am J Hematol. 2017 Nov;92(11):E626-E627. doi: 10.1002/ajh.24866. Epub 2017 Aug 17. No abstract available.

43.

Advancing infection prevention and antimicrobial stewardship through improvement science.

Leis JA.

BMJ Qual Saf. 2018 Feb;27(2):163-165. doi: 10.1136/bmjqs-2017-006793. Epub 2017 Jun 14. No abstract available.

PMID:
28615344
44.

Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs: A Pragmatic Multicenter Prospective Evaluation.

Leis JA, Palmay L, Ho G, Raybardhan S, Gill S, Kan T, Campbell J, Kiss A, McCready JB, Das P, Minnema B, Powis JE, Walker SAN, Ferguson H, Wong B, Weber E.

Clin Infect Dis. 2017 Oct 1;65(7):1059-1065. doi: 10.1093/cid/cix512.

PMID:
28575226
45.

Radiation safety in the cardiac catheterization lab: A time series quality improvement initiative.

Abuzeid W, Abunassar J, Leis JA, Tang V, Wong B, Ko DT, Wijeysundera HC.

Cardiovasc Revasc Med. 2017 Jul - Aug;18(5S1):S22-S26. doi: 10.1016/j.carrev.2017.04.009. Epub 2017 Apr 22.

PMID:
28483588
46.

Impact of two-step urine culture ordering in the emergency department: a time series analysis.

Stagg A, Lutz H, Kirpalaney S, Matelski JJ, Kaufman A, Leis J, McCready J, Powis J.

BMJ Qual Saf. 2018 Feb;27(2):140-147. doi: 10.1136/bmjqs-2016-006250. Epub 2017 May 3.

47.

Association of hematopoietic cell transplantation-specific comorbidity index with resource utilization after allogeneic transplantation.

Decook L, Chang YH, Slack J, Gastineau D, Leis J, Noel P, Palmer J, Sproat L, Sorror M, Khera N.

Bone Marrow Transplant. 2017 Jul;52(7):998-1002. doi: 10.1038/bmt.2017.70. Epub 2017 Apr 24.

PMID:
28436978
48.

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.

Ding W, LaPlant BR, Call TG, Parikh SA, Leis JF, He R, Shanafelt TD, Sinha S, Le-Rademacher J, Feldman AL, Habermann TM, Witzig TE, Wiseman GA, Lin Y, Asmus E, Nowakowski GS, Conte MJ, Bowen DA, Aitken CN, Van Dyke DL, Greipp PT, Liu X, Wu X, Zhang H, Secreto CR, Tian S, Braggio E, Wellik LE, Micallef I, Viswanatha DS, Yan H, Chanan-Khan AA, Kay NE, Dong H, Ansell SM.

Blood. 2017 Jun 29;129(26):3419-3427. doi: 10.1182/blood-2017-02-765685. Epub 2017 Apr 19.

49.

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

Larsen JT, Shanafelt TD, Leis JF, LaPlant B, Call T, Pettinger A, Hanson C, Erlichman C, Habermann TM, Reeder C, Nikcevich D, Bowen D, Conte M, Boysen J, Secreto C, Lesnick C, Tschumper R, Jelinek D, Kay NE, Ding W.

Am J Hematol. 2017 Aug;92(8):759-763. doi: 10.1002/ajh.24762. Epub 2017 Jun 1.

50.

Vestibulotoxicity with systemic gentamicin in different dosing regimens: Our experience in 46 patients.

Syed MI, Leis JA, Ilan O, Gold WL, Pothier DD, Rutka JA.

Clin Otolaryngol. 2017 Oct;42(5):1091-1095. doi: 10.1111/coa.12865. Epub 2017 Apr 17. No abstract available.

PMID:
28296174

Supplemental Content

Support Center